Search results
Results From The WOW.Com Content Network
The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child. The guidance was provided by pharmacists and doctors whose expertise was in the care of adults.
In 2023, NICE announced their decision to stop the supply of print BNF to NHS organisations in England. The same decision was made by Scotland and Wales. [ 1 ] [ 13 ] NHS workers and healthcare professionals in the HINARI group of developing nations are entitled to free access via MedicinesComplete following registration (requires provision of ...
The two main reference sources providing this information are the British National Formulary (BNF) and the Drug Tariff. There is a section in the Drug Tariff, known unofficially as the " Blacklist ", detailing medicines which are not to be prescribed under the NHS and must be paid for privately by the patient.
Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical standards. Pharmacopoeial standards are compliance requirements; that is, they provide the means for an independent judgement as to the overall quality of an article, and apply throughout the shelf-life of a product.
Pharmaceutical Press is the publishing arm of the Royal Pharmaceutical Society (formerly the Royal Pharmaceutical Society of Great Britain).It is a provider of independent pharmaceutical information.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
(August 2023) (Learn how and when to remove this message) ( Learn how and when to remove this message ) Irish Medicines Formulary (IMF) [ 1 ] [ 2 ] is a medicines reference for doctors, nurses, pharmacists and dentists, [ 3 ] providing medicines information which is medico-legally relevant in Ireland.
A British Approved Name (BAN) is the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP). [1] The BAN is also the official name used in some countries around the world, because starting in 1953, proposed new names were evaluated by a panel of experts from WHO in conjunction with the BP commission to ensure naming ...